Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$0.16 - $0.26 $800 - $1,300
5,000 New
5,000 $0
Q4 2021

Feb 14, 2022

SELL
$0.33 - $0.61 $1,650 - $3,050
-5,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$0.34 - $0.52 $1,700 - $2,600
5,000 New
5,000 $2,000
Q1 2021

May 17, 2021

SELL
$0.23 - $0.46 $1,150 - $2,300
-5,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$0.14 - $0.32 $700 - $1,600
5,000 New
5,000 $1,000
Q3 2019

Nov 12, 2019

SELL
$0.4 - $0.66 $2,000 - $3,300
-5,000 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$0.49 - $0.68 $2,450 - $3,400
5,000 New
5,000 $3,000
Q4 2018

Feb 13, 2019

SELL
$0.47 - $1.26 $2,350 - $6,300
-5,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$0.69 - $1.83 $3,449 - $9,150
5,000 New
5,000 $6,000

About IntelGenx Technologies Corp.


  • Ticker IGXT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 174,646,000
  • Market Cap $29.7M
  • Description
  • IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunc...
More about IGXT
Track This Portfolio

Track Monetary Management Group Inc Portfolio

Follow Monetary Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetary Management Group Inc with notifications on news.